| Jan-13-20 05:21PM | How Did Innoviva, Inc. (INVA) Compare Against Hedge Fund Darlings in 2019? Insider Monkey |
| Jan-09-20 02:50PM | Top Biotech Stocks for Q1 2020 Investopedia |
| Jan-08-20 05:50PM | Innoviva (INVA) Outpaces Stock Market Gains: What You Should Know Zacks |
| Jan-07-20 08:43AM | Is Innoviva, Inc. (NASDAQ:INVA) A Volatile Stock? Simply Wall St. |
| Dec-31-19 11:05AM | Jazz Enrolls First Patient in Phase II/III Leukemia Study Zacks |
| 11:01AM | Acceleron, Fulcrum Therapeutics Ink Deal for Pulmonary Disease Zacks |
| Dec-30-19 05:17PM | BeiGene Gets Approval for Lymphoma Drug Tislelizumab in China Zacks |
| 11:17AM | Top Ranked Value Stocks to Buy for December 30th Zacks |
| 10:23AM | Alnylam Stock Up More Than 61% YTD on Pipeline Progress Zacks |
| Dec-27-19 05:50PM | Innoviva (INVA) Stock Moves -0.84%: What You Should Know Zacks |
| Dec-26-19 09:55AM | Top Ranked Value Stocks to Buy for December 26th Zacks |
| Dec-24-19 09:16AM | AstraZeneca's Triple-Combo COPD Inhaler Gets China's Nod Zacks |
| Dec-20-19 09:28AM | Bausch's (BHC) Arazlo Gets FDA Approval for Acne Vulgaris Zacks |
| 08:19AM | Top Ranked Value Stocks to Buy for December 20th Zacks |
| Dec-19-19 10:02AM | Epizyme Stock Up on Positive Advisory Votes for Tazemetostat Zacks |
| Dec-18-19 05:45PM | Innoviva (INVA) Dips More Than Broader Markets: What You Should Know Zacks |
| 07:59AM | 5 Beaten-Down Biotech Stocks Set to Rebound in 2020 Zacks |
| Dec-17-19 11:50AM | Should Value Investors Buy Innoviva (INVA) Stock? Zacks |
| 10:25AM | Mallinckrodt Initiates Phase IV Study on Acthar for Keratitis Zacks |
| Dec-16-19 09:46AM | Horizon Therapeutics Eye Drug Gets Positive FDA Advisory Vote Zacks |
| Dec-12-19 02:34PM | BioCryst Submits NDA for Hereditary Angioedema Candidate Zacks |
| Dec-11-19 10:06AM | VistaGen Up on Fast Track Designation for Anxiety Disorder Drug Zacks |
| Dec-10-19 09:26AM | TG Therapeutics' Shares Soar on Positive Early-Stage Data Zacks |
| 08:24AM | Top Ranked Value Stocks to Buy for December 10th Zacks |
| Dec-09-19 04:31PM | Regeneron Reports Initial Data for Multiple Myeloma Drug Zacks |
| 09:59AM | Top Ranked Value Stocks to Buy for December 9th Zacks |
| Dec-06-19 09:57AM | Hedge Funds Have Never Been More Bullish On Innoviva, Inc. (INVA) Insider Monkey |
| Dec-05-19 10:02AM | Ra Pharmaceuticals Begins Phase II Study on Autoimmune Drug Zacks |
| Dec-03-19 09:36AM | Top Ranked Value Stocks to Buy for December 3rd Zacks |
| Nov-27-19 03:32AM | Sorrento Turns Down Two All-Cash Takeover Bids, Stock Jumps Zacks |
| Nov-25-19 09:18AM | Alexion Gets Approval for Label Expansion of Soliris in Japan Zacks |
| Nov-13-19 10:20AM | Surging Earnings Estimates Signal Upside for Innoviva (INVA) Stock Zacks |
| Nov-12-19 08:00AM | Value ETFs & Stocks Offering Real Value: 5 Top Picks Zacks |
| Oct-30-19 04:05PM | Innoviva Reports Third Quarter 2019 Financial Results Business Wire |
| Oct-26-19 12:36PM | Is Innoviva, Inc. (INVA) Going To Burn These Hedge Funds ? Insider Monkey |
| Oct-09-19 07:15AM | How Many Innoviva, Inc. (NASDAQ:INVA) Shares Did Insiders Buy, In The Last Year? Simply Wall St. |
| Oct-02-19 09:17AM | GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma Business Wire |
| Jul-24-19 04:05PM | Innoviva Reports Second Quarter 2019 Financial Results Business Wire |
| Jul-11-19 11:19AM | Moleculin Files New Patents for Cancer Candidate Annamycin Zacks |
| 06:17AM | Does The Data Make Innoviva, Inc. (NASDAQ:INVA) An Attractive Investment? Simply Wall St. |
| Jun-18-19 09:25AM | Celgene (CELG) Hits 52-Week High, Can the Run Continue? Zacks |
| Jun-11-19 09:40AM | How Does Innoviva, Inc. (NASDAQ:INVA) Affect Your Portfolio Volatility? Simply Wall St. |
| May-23-19 09:19AM | The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology Zacks |
| May-22-19 07:21AM | 5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon Zacks |
| May-15-19 10:20AM | Earnings Estimates Moving Higher for Innoviva (INVA): Time to Buy? Zacks |
| 09:35AM | New Strong Buy Stocks for May 15th Zacks |
| May-02-19 01:46PM | GSK's 3-in-1 inhalable drug shows promise in asthma study Reuters +7.10% |
| 12:18PM | Phase III CAPTAIN Study of Trelegy Ellipta in Patients with Asthma Meets Primary Endpoint Business Wire |
| May-01-19 07:52PM | Innoviva: 1Q Earnings Snapshot Associated Press |
| 04:09PM | Innoviva Reports First Quarter 2019 Financial Results Business Wire |
| Apr-30-19 03:43PM | Is Innoviva, Inc. (INVA) A Good Stock To Buy? Insider Monkey |
| Apr-24-19 03:23PM | Those Who Purchased Innoviva (NASDAQ:INVA) Shares Five Years Ago Have A 49% Loss To Show For It Simply Wall St. |
| Apr-08-19 10:00AM | 3 Top Biotech Stocks to Buy in April Motley Fool |
| Mar-08-19 08:00PM | A Dozen 13D Deals Barrons.com |
| 02:21PM | How Many Insiders Bought Innoviva, Inc. (NASDAQ:INVA) Shares? Simply Wall St. |
| Feb-19-19 05:48PM | Innoviva Inc (INVA) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com |
| Feb-15-19 04:27PM | Innoviva, Inc. -- Moody's announces completion of a periodic review of ratings of Innoviva, Inc. Moody's |
| Feb-07-19 02:39PM | Buy the Dip on This Pharma Stock Schaeffer's Investment Research |
| Feb-06-19 05:57PM | Innoviva: 4Q Earnings Snapshot Associated Press -6.00% |
| 04:05PM | Innoviva Reports Fourth Quarter 2018 Financial Results Business Wire |
| 08:15AM | Report: Developing Opportunities within Xcel Energy, Empire State Realty Trust, Innoviva, Tyler Technologies, Tower International, and Nathan's Famous Future Expectations, Projections Moving into 2019 GlobeNewswire |
| Jan-30-19 04:09PM | Mylan Pops After FDA Approves Its Knockoff Of Glaxo's Asthma Inhaler Investor's Business Daily -9.17% |
| Jan-22-19 01:37PM | Why Innoviva, Inc. (NASDAQ:INVA) Is An Attractive Investment To Consider Simply Wall St. |
| Jan-11-19 03:30PM | Dow Jones Gives Back Little Of Its 1,100-Point Rebound; 3 Signs Stock Market Bears Are Retreating Investor's Business Daily |
| Jan-01-19 09:21AM | 3 Under-the-Radar Value Stocks to Buy in 2019 Motley Fool |
| Dec-20-18 09:30AM | Is Innoviva (INVA) Stock Outpacing Its Medical Peers This Year? Zacks |
| Dec-17-18 03:10PM | IBD 50 Stocks To Watch: Innoviva Resilient As Broad Market Struggles Investor's Business Daily |
| Dec-14-18 12:39AM | Hedge Funds Arent Crazy About Innoviva, Inc. (INVA) Anymore Insider Monkey |
| Dec-06-18 09:37AM | 3 Reasons Momentum Stock Investors Will Love Innoviva (INVA) Zacks |
| Nov-23-18 12:03PM | Stocks Trim Losses As Consumer Stocks Rise At Start Of Holiday Shopping Season Investor's Business Daily +5.39% |
| Nov-20-18 04:25PM | IBD Stock Of The Day Breezes Toward Breakout On New Inhaler Uses Investor's Business Daily |
| Nov-13-18 09:22AM | Glaxo/Innoviva's Trelegy Ellipta Gets Line Extension in Europe Zacks |
| Nov-09-18 07:56AM | Moving Average Crossover Alert: Innoviva (INVA) Zacks |
| 07:01AM | Once-daily Trelegy Ellipta gains expanded COPD indication in Europe Business Wire |
| Nov-06-18 07:30AM | Research Report Identifies Oil States International, Brightcove, Electronics for Imaging, Cirrus Logic, Innoviva, and Marinus Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire |
| Nov-05-18 03:01PM | IBD 50 Stocks To Watch: This Stock Rallied Despite A Miss On Earnings And Revenue Investor's Business Daily |
| Oct-31-18 04:31PM | Innoviva: 3Q Earnings Snapshot Associated Press -6.31% |
| 04:05PM | Innoviva Reports Third Quarter 2018 Financial Results Business Wire |
| Sep-21-18 07:30AM | Trelegy Ellipta Receives Positive CHMP Opinion Supporting Expanded COPD Indication in Europe Business Wire |
| Sep-05-18 02:57PM | Should You Be Worried When Innoviva Incs (NASDAQ:INVA) Insiders Sell? Simply Wall St. |
| Aug-28-18 07:35AM | Report: Exploring Fundamental Drivers Behind Allscripts Healthcare Solutions, Dean Foods, Alder BioPharmaceuticals, Innoviva, Chegg, and TEGNA New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire |
| Jul-26-18 04:05PM | Innoviva Reports Second Quarter 2018 Financial Results Business Wire |
| Jul-17-18 12:33PM | GlaxoSmithKline Is More Than Just a 5% Dividend Income Play InvestorPlace |
| Jul-13-18 07:30AM | Free Technical Research on Insmed and Three More Biotech Equities ACCESSWIRE |
| Jun-26-18 12:02PM | Innoviva And Other Great Growth Stocks Simply Wall St. |
| 07:55AM | Recent Analysis Shows Church & Dwight Co., Innoviva, PTC Therapeutics, KBR, Murphy Oil, and F.N.B. Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire |
| Jun-15-18 10:21AM | 3 Top Healthcare Stocks to Buy in June Motley Fool |
| Jun-11-18 07:38AM | The Cheapest Drug Stocks to Buy Right Now Motley Fool |
| May-30-18 10:33AM | Glaxo/Innoviva File for Approval of Trelegy Ellipta in Japan Zacks |
| May-29-18 02:00AM | GSK Submits Regulatory Application in Japan for Once-Daily Single Inhaler Triple Therapy FF/UMEC/VI for Patients with COPD Business Wire |
| May-22-18 04:05PM | Innoviva Names Geoffrey Hulme as Interim Principal Executive Officer Business Wire |
| May-14-18 10:02AM | Top Cheap Stocks To Buy Simply Wall St. |
| May-08-18 08:25AM | Research Report Identifies ILG, Innoviva, iRobot, KBR, KapStone Paper and Packaging, and Lumentum with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire |
| May-01-18 07:50AM | Blog Exposure - INSYS Commences Phase-2 Clinical Trial of Cannabidiol Oral Solution for Treatment of Prader-Willi Syndrome ACCESSWIRE |
| Apr-26-18 08:23AM | Innoviva: 1Q Earnings Snapshot Associated Press |
| 08:00AM | Innoviva Reports First Quarter 2018 Financial Results Business Wire |
| Apr-24-18 12:55PM | Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients With COPD Business Wire |
| Apr-18-18 05:00PM | Landmark IMPACT Study Published in NEJM Shows Significant Benefits of Trelegy Ellipta for Patients with COPD Business Wire |
| Apr-03-18 09:42AM | Biotech Stock Tests Buy Zone, Gets New Approval For Asthma Drug Relvar Ellipta Investor's Business Daily |
| Mar-29-18 10:02AM | Flavor Of The Month: Innoviva And More Simply Wall St. |
